Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
FDA Approves Lutathera for Gastroenteropancreatic Neuroendocrine Tumors
HTML
Details
Locations
Year:
2018
Type:
article
Author:
Leah Lawrence
Language:
English
Topic:
Neuroendocrine Tumor Research Advances
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
177Lu-DOTATATE,
gastroenteropancreatic neuroendocrine tumors,
FDA drug approval,
somatostatin receptors,
peptide receptor radionuclide therapy,
targeted radionuclide therapy
show all 6
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2930901495
FWCI:
Cites:
Cited by:
Related to:
10